On ECHEMI
Home > Drugs > Hybio Pharmaceutical Co., Ltd.
Hybio Pharmaceutical Co., Ltd.
  • Founded in:

    2003-04-02
  • Country:

    China China
  • Address:

    Hanyu Innovation Industry Building, No. 7 Guansheng 4th Road, Guanlan High-tech Park, Longhua District, Shenzhen
  • Tax NO.:

    91440300748855818E
  • Registered Funds:

    883.241336 million yuan
  • Website:

  • Email:

Related Drugs
Sodium Ferulate for Injection
Sodium ferulate.
Name Description Content CAS NO. Registered Holders
Sodium ferulic

This product is a non-peptide endothelin receptor antagonist, which can antagonize endothelin-induced vasoconstriction, blood pressure increase and vascular smooth muscle cell proliferation, reduce vascular endothelial damage; increase NO synthesis, relax vascular smooth muscle; inhibit platelet aggregation, anti-coagulation, and improve blood rheology characteristics. This product can also inhibit cholesterol synthesis, lower blood lipids, scavenge free radicals, prevent lipid peroxidation damage; affect complement, enhance immune function, and have certain analgesic and antispasmodic effects.

More

This product is a non-peptide endothelin receptor antagonist, which can antagonize endothelin-induced vasoconstriction, blood pressure increase and vascular smooth muscle cell proliferation, reduce vascular endothelial damage; increase NO synthesis, relax vascular smooth muscle; inhibit platelet aggregation, anti-coagulation, and improve blood rheology characteristics. This product can also inhibit cholesterol synthesis, lower blood lipids, scavenge free radicals, prevent lipid peroxidation damage; affect complement, enhance immune function, and have certain analgesic and antispasmodic effects.

24276-84-4 8
Sodium Ferulate for Injection
Sodium ferulate.
Name Description Content CAS NO. Registered Holders
Sodium ferulic

This product is a non-peptide endothelin receptor antagonist, which can antagonize endothelin-induced vasoconstriction, blood pressure increase and vascular smooth muscle cell proliferation, reduce vascular endothelial damage; increase NO synthesis, relax vascular smooth muscle; inhibit platelet aggregation, anti-coagulation, and improve blood rheology characteristics. This product can also inhibit cholesterol synthesis, lower blood lipids, scavenge free radicals, prevent lipid peroxidation damage; affect complement, enhance immune function, and have certain analgesic and antispasmodic effects.

More

This product is a non-peptide endothelin receptor antagonist, which can antagonize endothelin-induced vasoconstriction, blood pressure increase and vascular smooth muscle cell proliferation, reduce vascular endothelial damage; increase NO synthesis, relax vascular smooth muscle; inhibit platelet aggregation, anti-coagulation, and improve blood rheology characteristics. This product can also inhibit cholesterol synthesis, lower blood lipids, scavenge free radicals, prevent lipid peroxidation damage; affect complement, enhance immune function, and have certain analgesic and antispasmodic effects.

24276-84-4 8
Sodium Ferulate for Injection
Sodium ferulate.
Name Description Content CAS NO. Registered Holders
Sodium ferulic

This product is a non-peptide endothelin receptor antagonist, which can antagonize endothelin-induced vasoconstriction, blood pressure increase and vascular smooth muscle cell proliferation, reduce vascular endothelial damage; increase NO synthesis, relax vascular smooth muscle; inhibit platelet aggregation, anti-coagulation, and improve blood rheology characteristics. This product can also inhibit cholesterol synthesis, lower blood lipids, scavenge free radicals, prevent lipid peroxidation damage; affect complement, enhance immune function, and have certain analgesic and antispasmodic effects.

More

This product is a non-peptide endothelin receptor antagonist, which can antagonize endothelin-induced vasoconstriction, blood pressure increase and vascular smooth muscle cell proliferation, reduce vascular endothelial damage; increase NO synthesis, relax vascular smooth muscle; inhibit platelet aggregation, anti-coagulation, and improve blood rheology characteristics. This product can also inhibit cholesterol synthesis, lower blood lipids, scavenge free radicals, prevent lipid peroxidation damage; affect complement, enhance immune function, and have certain analgesic and antispasmodic effects.

24276-84-4 8
Somatostatin for injection
The main ingredient is somatostatin, a synthetic cyclic tetradecapeptide
Name Description Content CAS NO. Registered Holders
Somatostatin

Inhibits the secretion of growth hormone, thyroid stimulating hormone, insulin and glucagon, and inhibits the secretion of gastric acid; affects the absorption, motility, visceral blood flow and nutritional function of the gastrointestinal tract; inhibits the secretion of gastrin, gastric acid and pepsin, thereby treating upper gastrointestinal bleeding; significantly reduces the blood flow to visceral organs without causing significant changes in systemic arterial blood pressure, and has certain value in the treatment of esophageal varicose bleeding; reduces the endocrine and exocrine secretions of the pancreas.

More

Inhibits the secretion of growth hormone, thyroid stimulating hormone, insulin and glucagon, and inhibits the secretion of gastric acid; affects the absorption, motility, visceral blood flow and nutritional function of the gastrointestinal tract; inhibits the secretion of gastrin, gastric acid and pepsin, thereby treating upper gastrointestinal bleeding; significantly reduces the blood flow to visceral organs without causing significant changes in systemic arterial blood pressure, and has certain value in the treatment of esophageal varicose bleeding; reduces the endocrine and exocrine secretions of the pancreas.

51110-01-1 28
Somatostatin for injection
The main ingredient is somatostatin, a synthetic cyclic tetradecapeptide
Name Description Content CAS NO. Registered Holders
Somatostatin

Inhibits the secretion of growth hormone, thyroid stimulating hormone, insulin and glucagon, and inhibits the secretion of gastric acid; affects the absorption, motility, visceral blood flow and nutritional function of the gastrointestinal tract; inhibits the secretion of gastrin, gastric acid and pepsin, and is used to treat upper gastrointestinal bleeding; reduces the blood flow to visceral organs without significantly changing the systemic arterial blood pressure, and is suitable for the treatment of esophageal varicose bleeding; reduces the endocrine and related functions of the pancreas.

More

Inhibits the secretion of growth hormone, thyroid stimulating hormone, insulin and glucagon, and inhibits the secretion of gastric acid; affects the absorption, motility, visceral blood flow and nutritional function of the gastrointestinal tract; inhibits the secretion of gastrin, gastric acid and pepsin, and is used to treat upper gastrointestinal bleeding; reduces the blood flow to visceral organs without significantly changing the systemic arterial blood pressure, and is suitable for the treatment of esophageal varicose bleeding; reduces the endocrine and related functions of the pancreas.

51110-01-1 28
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.